Evidence map›Paper›PMID 23818862›Full record

ArticlePLoS genetics2013

Survival response to increased ceramide involves metabolic adaptation through novel regulators of glycolysis and lipolysis.

Niraj K Nirala, Motiur Rahman, Stanley M Walls, Alka Singh, Lihua Julie Zhu, Takeshi Bamba, Eiichiro Fukusaki, Sargur M Srideshikan, Greg L Harris, Y Tony Ip and 2 more

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 32 citations in OpenAlex.

  1. Transcriptional Control of Lipid Metabolism.Advances in experimental medicine and biology · 2026
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 5 institutions in 2 countries.

Niraj K NiralaProgram in Gene Function and Expression, University of Massachusetts Medical School, Worcester, Massachusetts, USA.
Motiur Rahman
Stanley M Walls
Alka Singh
Lihua Julie Zhu
Takeshi Bamba
Eiichiro Fukusaki
Sargur M Srideshikan
Greg L Harris
Y Tony Ip
Rolf Bodmer
Usha R Acharya
University of Massachusetts Chan Medical School · USOsaka University · JPSan Diego State University · USNational Cancer Institute · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

PILOT AND FEASIBILITY PROGRAMP30DK032520 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI CZECH, MICHAEL P · 1986 to 2010
$14.6M
Genetic analysis of damage-induced intestinal stem cell division in DrosophilaR01DK083450 · NIDDK · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI IP, Y. TONY · 2010 to 2024
$4.7M
Ceramide Metabolism and Photoreceptor HomeostasisR01EY016469 · NEI · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI ACHARYA, USHA R · 2005 to 2013
$2.9M
NEI NIH HHS R01 EY016469NEI NIH HHS R01EY016469NIDDK NIH HHS DK32520NIDDK NIH HHS DK83450NIDDK NIH HHS P30 DK032520NIDDK NIH HHS R01 DK083450
6 · The paper itself

Abstract

The sphingolipid ceramide elicits several stress responses, however, organisms survive despite increased ceramide but how they do so is poorly understood. We demonstrate here that the AKT/FOXO pathway regulates survival in increased ceramide environment by metabolic adaptation involving changes in glycolysis and lipolysis through novel downstream targets. We show that ceramide kinase mutants accumulate ceramide and this leads to reduction in energy levels due to compromised oxidative phosphorylation. Mutants show increased activation of Akt and a consequent decrease in FOXO levels. These changes lead to enhanced glycolysis by upregulating the activity of phosphoglyceromutase, enolase, pyruvate kinase, and lactate dehydrogenase to provide energy. A second major consequence of AKT/FOXO reprogramming in the mutants is the increased mobilization of lipid from the gut through novel lipase targets, CG8093 and CG6277 for energy contribution. Ubiquitous reduction of these targets by knockdown experiments results in semi or total lethality of the mutants, demonstrating the importance of activating them. The efficiency of these adaptive mechanisms decreases with age and leads to reduction in adult life span of the mutants. In particular, mutants develop cardiac dysfunction with age, likely reflecting the high energy requirement of a well-functioning heart. The lipases also regulate physiological triacylglycerol homeostasis and are important for energy metabolism since midgut specific reduction of them in wild type flies results in increased sensitivity to starvation and accumulation of triglycerides leading to cardiac defects. The central findings of increased AKT activation, decreased FOXO level and activation of phosphoglyceromutase and pyruvate kinase are also observed in mice heterozygous for ceramide transfer protein suggesting a conserved role of this pathway in mammals. These data reveal novel glycolytic and non-autonomous lipolytic pathways in response to increased ceramide for sustenance of high energy demanding organ functions like the heart.

Indexed as

AnimalsCeramidesDrosophila melanogasterEnergy MetabolismForkhead Box Protein O1Forkhead Transcription FactorsGene Expression RegulationGlycolysisLipolysisMiceOncogene Protein v-aktPhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)Protein Serine-Threonine KinasesSignal TransductionStress, Physiologicalceramide kinaseCeramidesCol4a3bp protein, mouseForkhead Box Protein O1Forkhead Transcription FactorsFoxo1 protein, mouseOncogene Protein v-aktPhosphatidylinositol 3-KinasesPhosphotransferases (Alcohol Group Acceptor)Protein Serine-Threonine Kinases

Identifiers

PMID23818862
PMCPMC3688504
OpenAlexW2078680759

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.